hepatitis c treatment
This new class of HCV drugs, which are much easier on the human body and virtually free of side effects, attacks the virus directly and can reduce the viral load to zero when taken correctly.
Pamela Anderson is right.
How many more people have to be infected or die from hep C before we speak up? Or, do we have to wait until we restrict medical coverage for all diseases, and perhaps lose a few toes before we protest.
I'll spell out the vows that I believe all the key stakeholders in the fight against hepatitis C should follow in the year ahead.
Thursday was panning out to be a seemingly ordinary day in the goings on of the International AIDS Conference when the shouts of a group of protesters began rumbling throughout the halls. It would appear that, with signs reading "Gilead Kills," these protestors were up in arms over the pharmaceutical company that holds the overwhelming majority of HIV medications.
Just 25 years ago, scientists identified the previously unknown virus that has since killed hundreds of thousands of Americans. It now threatens the health of millions more.
Larger questions loom Many payers and pharmacy benefit managers have begun to push back against Sovaldi's price, with some
Several drugmakers, including Gilead Sciences Inc, AbbVie and Merck & Co are developing a new generation of all-oral hepatitis
1. Establishment of National Hepatitis Testing Day. The original Action Plan called for the establishment of this annual
Sofosbuvir fights the hepatitis C virus by directly interfering with one of the enzymes that the virus needs to duplicate
We know that political commitment and community mobilization can make the difference. For those who say that treatment is too complicated or that pharmaceutical companies will always prioritize profit over people, we should say: we've been here before.
MORE ROBUST DATA April 23 (Reuters) - AbbVie Inc's experimental hepatitis C treatment cured up to 96 percent of patients
Nov 10 (Reuters) - Gilead Sciences Inc on Saturday reported a 100 percent cure rate using a combination of drugs in a small
A Call for Baby Boomers to Undergo Testing for Hepatitis C, a Once Lethal Disease With New, Potent Treatments
The Centers for Disease Control and Prevention has taken the unprecedented step of declaring a whole generation at higher than average risk of hepatitis C infection.
Patients received the combination therapy for 12 weeks and were checked 24 weeks later for signs of the virus in the blood